
Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
Wonderful Sea shores All over the Planet - 2
Why this Iranian island looks like Mars after it rains - 3
Unpaid caregiving work can feel small and personal, but that doesn’t take away its ethical value - 4
Consume Fat Quick: 10 Demonstrated Activities for Ideal Outcomes - 5
Top 15 Online Entertainment Stages for Individual Marking
‘The White Lotus’ sparked online interest in risky anxiety pills, study says
International issues on the agenda as Frances's Macron visits China
Dominating Capable Mastercard Utilization: Key Contemplations
Supportive Tips On Home loans For First-Time Home Purchasers
Europe pledges over €15bn for clean energy for Africa
'The Housemaid' movie with Sydney Sweeney and Amanda Seyfried premieres this month. What the stars have said about the psychological thriller.
Insane Realities That Will Make You Reconsider How you might interpret History
Getting through a Lifelong Change: Individual Examples of overcoming adversity
Merz visit highlights new strategic, and strained, Germany-Israel bond












